Less selling, more science can best help doctors navigate complex new cancer treatments, report suggests The future of cancer drug marketing will be about helping oncologists understand the complexities of precision medicine and how new advances in targeted therapies can help their specific patients. That means drug companies will need to focus less on the selling, more on the science. And theyâll need real world data to prove their drugs work as well in the âmessy setting of everyday lifeâ as they do in the clinic, a new Accenture survey of 120 oncologists in the U.S. and Germany suggests. âThe clinical trials that are the basis for your promotional materials â those are just your ticket to play,â said AndreÌ T. Dahinden, a managing director of global precision oncology in Accentureâs Life Sciences division. Oncologists are asking, âWhat do these medicines really do in reality?â With the number of cancer drugs and drug combinations growing exponentially, itâs less likely a single sales rep can answer all of a doctorâs questions, said Dahinden. The need for more scientific guidance is especially true for community practice oncologists, who are working outside the realm of specialized cancer centers, he added.â https://lnkd.in/guVFUQGr #MSL #FSTP #BCMSLcert #BoardCertifiedMSL #medicalscienceliaison medical science liaison #Medicalaffairs medical affairs #Pharmacist #PHD #postdoc #pharmaceuticals #medicalaffairs #postdoc #pharma #pharmacy #clinicalresearch https://www.instagram.com/from_science_to_pharma/p/CZGjXXwJSfV/?utm_medium=tumblr















